THE EQUAL-qual Programme

1. Objectives of the EQUAL-qual programme

Today the polymerase chain reaction (PCR) is still one of the most powerful techniques used in many laboratories for molecular biology. PCR is extensively used in diverse fields of HealthCare as pathology, clinical chemistry, microbiology, and cytogenetics. However, external quality control programmes (EQA) designed to monitor the performance of PCR and PCR-related assays have been very limited in Europe. The EQUAL-qual program permits the evaluation of several analytical aspects common to the majority of the molecular tests based on qualitative PCR.

The program has been designed to evaluate PCR assays at three control levels:

1. DNA extraction (quality and quantity);
2. PCR performances (specificity and efficiency);
3. Interpretation of the results after electrophoresis.


2. Participant selection

Participation is open to all laboratories carrying out PCR based assays within the EU. Clinical laboratories of different medical professions (e.g. Clinical Chemistry, Pathology, Human Genetics, Microbiology, Forensics) are especially invited to join the programme. In the EQUAL-qual program, up to 423 Laboratories can participate (see the geographical distribution of participants at Description of the EQUAL Programmes). Participation is free.


3. What do you need to participate?

Participating laboratories need all the facilities to perform a PCR, like a thermal cycler, a spectrophotometer (UV), and a system for post-PCR analysis (like a submarine gel-electrophoresis system).
You will be requested to use your thermal cycler/s and the reagents commonly in use in your laboratory. Also instruments to record your PCR results (self-developing photos or image analysers) are necessary.


4. What will you find in the provided EQUAL-qual kit? Which actions do you have to do?

This is the list of the material included in the EQUAL-qual kit and of the actions to be performed in your laboratory.

Sample/reagent Concentration Actions
    If necessary extract DNA and determine:
DNA quantity
DNA quality
(A260/A280 ratio)

Report results

PCR with primer-
set A + B.


Report results

Send PCR products to project coordinator
Sample 1
1200 µL blood (citrate)
Blood contains
4 – 10 109/L
leukocytes
X
X
X
Sample 2
1200 µL blood (citrate)
Blood contains
4 – 10 109/L
leukocytes
X
X
X
Sample 3
50 µL DNA sample
[DNA] ca. 30 ng/µL
X
X
X
Sample 4
50 µL DNA sample
[DNA] ca. 30 ng/µL
X
X
X
Reagent A
Primerset A 40 µL
20 µmol/L
Reagent B
Primerset B 40 µL
20 µmol/L


5. Description of the actions

A detailed description of the material enclosed in the EQUAL-qual Kit and of the actions to be performed will be enclosed in the EQUAL-qual Kit.

6. Time Schedule of the survey

Deadline for application November, 6, 2004
Shipment of the EQUAL-qual kit to participants starts October 2004
ends December 2004
Phase of analysis in the labs, uploading of the results and shipment of the samples October, 2004 - February, 2005
Closing of the survey February 26, 2005
Re-evaluation of materials at the facilities of the organizers until end of April 2005
Statistical analysis on the Web site May 2005
Back-Reporting May 2005
Training Courses planned in the period July-October 2005

7. Do you want to know more on it?

Previous experiences have been performed at National levels and some of them have been published (see the Links page). Do you need further information? Please send a message to A. Martens by e-mail (a.martens@twenteborg.nl) or by mail to:

A. Martens, MD
Clinical Laboratory
Ziekenhuisgroep Twente
Postbox 7600
7600 SZ Almelo
The Netherlands

8. Do you want to join the EQUAL-qual program?

Please fill your application form by clicking here.